GRIFOLS | GRF - Sales Revenues


GRIFOLS reported EUR1.7B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Alcon AG USD 2.69B 10M Mar/2026
Almirall EUR 547.63M 12.83M Dec/2025
Amadeus IT EUR 1.68B 58.3M Mar/2026
Amarin USD 49.22M 451K Dec/2025
argenx SE USD 1.12B 0 Mar/2026
AstraZeneca USD 15.29B 213M Mar/2026
Bayer EUR 13.41B 1.97B Mar/2026
Cie Automotive EUR 1.05B 908.2M Mar/2026
Demant DKK 6.25B 800M Dec/2025
Ence Energia y Celulosa EUR 153.9M 33.25M Mar/2026
Essilor EUR 14.47B 7.6B Dec/2025
Ferrovial EUR 2.72B 306M Dec/2025
Fresenius EUR 5.74B 140M Mar/2026
Fresenius Medical Care EUR 4.61B 460M Mar/2026
Genmab DKK 1.06B 36M Dec/2025
GlaxoSmithKline GBP 7.63B 991M Mar/2026
GRIFOLS EUR 1.7B 280M Mar/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Inditex EUR 8.75B 2.94B Mar/2026
Lakefront Biotherapeutics EUR 6.5M 894.32M Mar/2026
Merck EUR 5.13B 120M Mar/2026
Novartis USD 13.11B 226M Mar/2026
Philips EUR 3.91B 1.19B Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.24B 60M Mar/2026
Smith & Nephew USD 3.18B 353M Dec/2025
UCB EUR 4.25B 764M Dec/2025
Viscofan EUR 305M 10.12M Mar/2026